Breast cancer (BC) patients frequently have accelerated bone loss because of chemotherapy, inducing premature menopause or aromatase inhibitor (AI) therapy, lowering estrogen levels, thus increasing fracture rate [3,4]. The gene discussed is CYP19A1; the disease is breast cancer.